Glucocorticoid therapy regulates podocyte motility by inhibition of Rac1
Abstract Nephrotic syndrome (NS) occurs when the glomerular filtration barrier becomes excessively permeable leading to massive proteinuria. In childhood NS, immune system dysregulation has been implicated and increasing evidence points to the central role of podocytes in the pathogenesis. Children...
Guardado en:
Autores principales: | James C. McCaffrey, Nicholas J. Webb, Toryn M. Poolman, Maryline Fresquet, Cressida Moxey, Leo A. H. Zeef, Ian J. Donaldson, David W. Ray, Rachel Lennon |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/964db73076a04303b20e5d2795d70cae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PLA2R binds to the annexin A2-S100A10 complex in human podocytes
por: Maryline Fresquet, et al.
Publicado: (2017) -
Activation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney disease.
por: Andrea Babelova, et al.
Publicado: (2013) -
Glucocorticoid receptor wields chromatin interactions to tune transcription for cytoskeleton stabilization in podocytes
por: Hong Wang, et al.
Publicado: (2021) -
FARP1, ARHGEF39, and TIAM2 are essential receptor tyrosine kinase effectors for Rac1-dependent cell motility in human lung adenocarcinoma
por: Mariana Cooke, et al.
Publicado: (2021) -
3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening
por: Lorna J. Hale, et al.
Publicado: (2018)